Recurrent steatosis following liver transplant for non-alcoholic steatohepatitis (NASH) or cryptogenic cirrhosis (CC); Histomorphologic and clinical follow-up in 231 patients

被引：0
作者：
Punia, J. N. [1 ]
Shah, V. V. [1 ]
Sherbondy, M. A. [1 ]
机构：
[1] Henry Ford Hosp, Detroit, MI 48202 USA
来源：
LABORATORY INVESTIGATION | 2007年 / 87卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1329
引用
收藏
页码：290A / 290A
页数：1
相关论文
共 50 条
  • [1] Recurrent steatosis following liver transplant for non-alcoholic steatohepatitis (NASH) or cryptogenic cirrhosis (CC); Histomorphologic and clinical follow-up in 231 patients
    Punia, J. N.
    Shah, V. V.
    Sherbondy, M. A.
    MODERN PATHOLOGY, 2007, 20 : 290A - 290A
  • [2] Non-alcoholic fatty liver disease (NAFLD) after orthotopic liver transplantation (OLT) in patients with cryptogenic cirrhosis (CC) and non-alcoholic steatohepatitis (NASH)
    Amaro, R
    Montalbano, M
    Acosta, RC
    Concha, R
    Weppler, D
    Neff, GW
    O'Brien, CB
    Molina, EG
    Schiff, ER
    Tzakis, AG
    GASTROENTEROLOGY, 2001, 120 (05) : A118 - A118
  • [3] Non-alcoholic fatty liver disease after liver transplantation in patients with non-alcoholic steatohepatitis and cryptogenic cirrhosis: the impact of pre-transplant graft steatosis
    Eshraghian, Ahad
    Nikeghbalian, Saman
    Kazemi, Kourosh
    Shamsaeefar, Alireza
    Geramizadeh, Bita
    Malek-Hosseini, Seyed Ali
    HPB, 2020, 22 (04) : 521 - 528
  • [4] Recurrence of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) Following Liver Transplantation for NASH Cirrhosis
    Matsuoka, Lea
    Slaughter, James
    Campbell, Kathyrn
    Kerr, Ashlie
    Hamel, Stephanie
    Garza, Carissa
    Chotai, Pranit
    Alexopoulos, Sophoclis
    Scanga, Andrew
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 15 - 15
  • [5] Systematic review: Does the evidence support an association between cryptogenic cirrhosis (CC) and non-alcoholic steatohepatitis (NASH)?
    Angtuaco, TL
    Raj, V
    Oprescu, FG
    Beisel, JC
    Moore, JD
    Russell, BD
    Co, JM
    Howden, CW
    GASTROENTEROLOGY, 2003, 124 (04) : A383 - A384
  • [6] Liver Transplantation (LT) for Cryptogenic Cirrhosis (CC) and Non-alcoholic Steatohepatitis (NASH) Cirrhosis: Twenty-Two Years Data from the Scientific Registry of Transplant Recipients (SRTR)
    Younossi, Zobair M.
    Stepanova, Maria
    Locklear, Cameron T.
    Jacobson, Ira
    Mishra, Alita
    Trimble, Gregory
    Erario, Madeline
    Venkatesan, Chapy
    Younossi, Issah
    Arsalla, Aimal
    Keo, Wisna'odom
    Goodman, Zachary D.
    HEPATOLOGY, 2017, 66 : 899A - 900A
  • [7] Will non-invasive testing replace liver biopsy in the diagnosis and follow-up of non-alcoholic steatohepatitis (NASH)?
    Pons Romero, F.
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2009, 101 (08) : 521 - 527
  • [8] LONG TERM FOLLOW-UP OF PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS
    Lafferty, H.
    Evans, C. D.
    Oien, K. A.
    Mills, P. R.
    GUT, 2012, 61 : A99 - A99
  • [9] Recurrent disease after liver transplantation (OLT) for non-alcoholic steato-hepatitis (NASH) and cryptogenic cirrhosis (CC): A cause for concern
    Almarastani, Mohamad N.
    Sherbondy, Mary Ann
    Brown, Kimberly
    Moonka, Dilip
    Gordon, Stuart
    Arenas, Juan
    Kim, Dean
    Yoshida, Atsushi
    Malinzak, Lauren
    Raoufi, Mohammad
    Abouljoud, Marwan
    HEPATOLOGY, 2006, 44 (04) : 653A - 654A
  • [10] Clinical Predictors of Recurrent Non-Alcoholic Steatohepatitis Following Liver Transplantation for Non-Alcoholic Fatty Liver Disease
    Stein, L.
    Dunn, W.
    Nguyen, H.
    Bhasin, D.
    Pollinger, H.
    Johnson, M.
    Shrestha, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 703 - 703
12345